Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on monoclonal antibody therapeutics market provides
in-depth analysis of segments and sub-segments in the global as well as
regional monoclonal antibody therapeutics market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
monoclonal antibody therapeutics market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of global monoclonal antibody therapeutics market. According to the
report, the global monoclonal antibody therapeutics market is projected to grow
at a CAGR of 12.80% over the forecast period of 2019-2025.
A monoclonal antibody therapeutics
is a form of immunotherapy that helps in stimulating the patient's immune
system and it prevents tumor growth by blocking specific cell receptors.
Monoclonal antibodies based therapeutics are growing with the advent of
mammalian cell culture, process, and formulation technology. Monoclonal
antibodies are used in the treatment of several major diseases such as
cardiovascular and infectious diseases, autoimmune, cancer and inflammation.
Growing adoption of monoclonal
antibody therapeutics in cancer treatments drives the growth of monoclonal
antibody therapeutics market. Monoclonal antibody drugs procure natural immune
system to fight cancer. Monoclonal antibodies are beneficial to treat cancer in
several ways as it blocks the cell growth, flagging cancer cells prevents
blood vessel growth and blocks immune system inhibitors. Furthermore, rising
use of monoclonal antibodies for the treatment of autoimmune diseases
particularly in rheumatoid arthritis and multiple sclerosis boosts the growth
of monoclonal antibody therapeutics market. Rapid development in the hybridoma
technique and increasing approvals of monoclonal antibodies for the treatment
of several diseases contribute to the growth of monoclonal antibody
therapeutics market. Increasing prevalence of Alzheimer's disease, cancer,
autoimmune diseases and growing awareness regarding several diseases fuels the
growth of monoclonal antibody therapeutics market. However, the high cost of
monoclonal antibodies may hamper the growth of monoclonal antibody therapeutics
market. Moreover, increasing investment in research and development, as well as
drug approvals for the treatment of several diseases, provides beneficial
opportunities for the monoclonal antibody therapeutics market.
Geographically, North America
dominated the monoclonal antibody therapeutics market. Approval of monoclonal
antibodies by the US FDA, development in healthcare infrastructure, huge
expenditure and investment in research and development activities contribute to
the growth of monoclonal antibody therapeutics market in the region. According
to a recent study by American Cancer Society researchers, at least 42% of newly
diagnosed cancers in the US, about 740,000 cases in 2019. The monoclonal
antibody therapeutics market in the Asia Pacific region is expected to grow at
a moderate rate, owing to increasing population and awareness of several
diseases and treatments, as well as increasing healthcare expenditure in the
region. According to the world health organization, cancer is the second
leading cause of death globally and is estimated to account for 9.6 million
death in 2018. Europe accounts for 23.4% of the global cancer cases and 20.3%
of cancer deaths.
The report on global monoclonal
antibody therapeutics market covers segments such as end users, based on
source, and application. On the basis of end users, the sub-markets
include research institute, private clinics, and hospitals. On the basis
of based on source, the sub-markets include humanized, human, chimeric, and
others. On the basis of application, the sub-markets include cancer,
ophthalmological diseases, hematological diseases, infectious diseases,
autoimmune diseases, and others.
The report provides profiles of
the companies in the market such as Novartis AG, Amgen Inc., AbbVie Inc., Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Sanofi, F. Hoffmann-La Roche Ltd, Pfizer Inc, Bayer AG, and GlaxoSmithKline Plc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of monoclonal antibody therapeutics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.